Abstract
Purpose
To describe the different types of vitreomacular interface abnormalities (VMIA) seen on optical coherence tomography (OCT) in type 2 macular telangiectasia (MacTel) and explain the possible reasons for its development.
Methods
In this retrospective cross-sectional study, type 2 MacTel eyes with macular volumetric OCT imaging protocol were included to identify different types of VMIA such as abnormal PVD, vitreomacular traction (VMT), ERM, and lamellar and full-thickness macular hole. The VMIA findings were then correlated with different MacTel disease stages and visual acuity.
Results
One thousand forty-three OCTs of 332 type 2 MacTel eyes from 169 patients at different visits were examined. VMIA was detected in 709 (68%) of those OCT scans in 216 (65%) eyes. There were 273 (39%), 31 (4%), 89 (13%), 7 (1%), and 381 (54%) OCT scans with vitreomacular adhesion, VMT, ERM, and inner and outer lamellar macular holes discovered respectively. VMIA eyes had a high frequency of abnormal PVD (p = 0.001) and retinal pigment clumps (RPCs) [p = 0.032]. Eyes with abnormal PVD (p = 0.034) and RPC (p = 0.000) had a higher rate of ERM development. RPC was linked to an increased risk of developing ERM (odd ratio 2.472; 95% CI 1.488–4.052). RPC and ERM contributed significantly to poor visual acuity (0.661 ± 0.416, 20/92).
Conclusion
OCT reveals a high frequency of VMIA in advanced type 2 MacTel eyes. RPC could be responsible for the development of anomalous PVD, as well as subsequent VMIAs and ERM. Additional work is required to examine the long-term changes and surgical outcomes of these eyes.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Levison AL, Kaiser PK (2014) Vitreomacular interface diseases: diagnosis and management. Taiwan J Ophthalmol 4:63–68. https://doi.org/10.1016/j.tjo.2013.12.001
Mikhail M, Stewart S, Seow F et al (2018) Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 256:1411–1418. https://doi.org/10.1007/s00417-018-4009-6
Elkayal H, Bedda AM, El-Goweini H et al (2021) Pars plana vitrectomy versus intravitreal injection of ranibizumab in the treatment of diabetic macular edema associated with vitreomacular interface abnormalities. J Ophthalmol 2021:6699668. https://doi.org/10.1155/2021/6699668
Furashova O, Engelmann K (2020) To peel or not to peel: pars plana vitrectomy with macular membrane peel in eyes with abnormalities of vitreomacular interface and coexisting dry age-related macular degeneration. Clin Ophthalmol Auckl NZ 14:389–396. https://doi.org/10.2147/OPTH.S240480
Vogt D, Stefanov S, Guenther SR et al (2020) Comparison of vitreomacular interface changes in myopic foveoschisis and idiopathic epiretinal membrane foveoschisis. Am J Ophthalmol 217:152–161. https://doi.org/10.1016/j.ajo.2020.04.023
Fang D, Wang L, Chen L et al (2021) Vitreomacular interface abnormalities in myopic foveoschisis: correlation with morphological features and outcome of vitrectomy. Front Med 8:796127. https://doi.org/10.3389/fmed.2021.796127
McKibbin M, Farragher T, Shickle D (2017) Vitreoretinal interface abnormalities in middle-aged adults with visual impairment in the UK Biobank study: prevalence, impact on visual acuity and associations. BMJ Open Ophthalmol 1:e000057. https://doi.org/10.1136/bmjophth-2016-000057
Liew G, Nguyen H, Ho I-V et al (2021) Prevalence of vitreoretinal interface disorders in an Australian population: the Blue Mountains Eye Study. Ophthalmol Sci 1:100019. https://doi.org/10.1016/j.xops.2021.100019
Liesenborghs I, De Clerck EEB, Berendschot TTJM et al (2018) Prevalence of optical coherence tomography detected vitreomacular interface disorders: the Maastricht Study. Acta Ophthalmol (Copenhagen) 96:729–736. https://doi.org/10.1111/aos.13671
Ben Ghezala I, Seydou A, Gabrielle P-H et al (2021) Epidemiology of vitreomacular interface abnormalities using macular spectral-domain optical coherence tomography in an elderly population (the Montrachet Study). Retina 41:60–67. https://doi.org/10.1097/IAE.0000000000002802
Stalmans P, Duker JS, Kaiser PK et al (2013) Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina Phila Pa 33:2003–2011. https://doi.org/10.1097/IAE.0b013e3182993ef8
Charbel Issa P, Gillies MC, Chew EY et al (2013) Macular telangiectasia type 2. Prog Retin Eye Res 34:49–77. https://doi.org/10.1016/j.preteyeres.2012.11.002
Gass JD, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 100:1536–1546
Gomes FC, Felix JPF, Nascimento MA, Lira RPC (2014) Epiretinal membrane formation associated with idiopathic macular telangiectasia: case report. Arq Bras Oftalmol 77:264–266. https://doi.org/10.5935/0004-2749.20140067
Cabral D, Ramtohul P, Kaden TR et al (2022) Hyperpigmented epiretinal membrane in macular telangiectasia type 2: imaging characteristics and correlation with transretinal pigment migration. Eye Lond Engl. https://doi.org/10.1038/s41433-022-02260-7
Charbel Issa P, Scholl HPN, Gaudric A et al (2009) Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. Eye Lond Engl 23:435–441. https://doi.org/10.1038/sj.eye.6703003
Ayachit AG, Reddy LU, Joshi S, Ayachit GS (2019) Epiretinal neovascularization: a novel OCT angiography finding in macular telangiectasia type 2. Ophthalmol Retina 3:516–522. https://doi.org/10.1016/j.oret.2019.01.022
Duker JS, Kaiser PK, Binder S et al (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611–2619. https://doi.org/10.1016/j.ophtha.2013.07.042
Venkatesh R, Reddy NG, Mishra P et al (2022) Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity. Int J Retina Vitr 8:26. https://doi.org/10.1186/s40942-022-00378-0
Venkatesh R, Agrawal S, Reddy NG et al (2022) Characteristics of retinal pigment clumps in type 2 macular telangiectasia (MacTel). Eye Lond Engl. https://doi.org/10.1038/s41433-022-02065-8
Idrees S, Sridhar J, Kuriyan AE (2019) Proliferative vitreoretinopathy: a review. Int Ophthalmol Clin 59:221–240. https://doi.org/10.1097/IIO.0000000000000258
Fraser-Bell S, Guzowski M, Rochtchina E et al (2003) Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology 110:34–40. https://doi.org/10.1016/s0161-6420(02)01443-4
Snead DRJ, James S, Snead MP (2008) Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation. Eye 22:1310–1317. https://doi.org/10.1038/eye.2008.36
Ngan ND, Cuong NV, Trung NL et al (2019) Clinical characteristics and histopathology of idiopathic epiretinal membrane in Vietnam. Open Access Maced J Med Sci 7:4324–4328. https://doi.org/10.3889/oamjms.2019.384
Author information
Authors and Affiliations
Contributions
RV, JC – conceptualizing the study, data acquisition, analyzing the data, statistics and results, interpreting the findings, writing & reviewing the manuscript.
YJP, RM, AH, SP, RS – Data acquisition and analyzing the data.
NKY – critically reviewing the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the (place name of institution and/or national research committee) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Approval was obtained from Narayana Nethralaya Institutional Review Board and Ethics committee (C-2022–12-003).
Consent for publication
Obtained from the patients.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Venkatesh, R., Mangla, R., Handa, A. et al. Vitreomacular interface abnormalities in type 2 macular telangiectasia (MacTel). Graefes Arch Clin Exp Ophthalmol 262, 1455–1463 (2024). https://doi.org/10.1007/s00417-023-06330-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-023-06330-8